Home/Filings/4/0001209191-24-000460
4//SEC Filing

Basta Steven L 4

Accession 0001209191-24-000460

CIK 0001566044other

Filed

Jan 2, 7:00 PM ET

Accepted

Jan 3, 5:10 PM ET

Size

5.7 KB

Accession

0001209191-24-000460

Insider Transaction Report

Form 4
Period: 2024-01-01
Basta Steven L
DirectorChief Executive Officer
Transactions
  • Award

    Stock Option (right to buy)

    2024-01-01+20,00020,000 total
    Exercise: $2.33Exp: 2033-12-31Common Stock (20,000 underlying)
Footnotes (1)
  • [F1]The shares subject to the option vest on January 1, 2025, subject to the Reporting Person's continuous service through such date.

Issuer

VYNE Therapeutics Inc.

CIK 0001566044

Entity typeother

Related Parties

1
  • filerCIK 0001417397

Filing Metadata

Form type
4
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 5:10 PM ET
Size
5.7 KB